Condition: Neisseria Gonorrheae Infection · Sponsor: Duke University
The goal of this study is to learn if a few investigational tests can correctly find the gene mutation (mutant allele gyrA 91F) that predicts ciprofloxacin resistance in clinical specimens that harbor Neisseria gonorrhoeae. The main question the study aims to answer: Can the investigational reflex test find the correct gene mutation (Neisseria gonorrhoeae gyrA 91F or gyrA 91S) as compared to the sequenced result? Specimens that are collected for routine clinical care and harbor Neisseria gonorrhoeae will be evaluated in this study.
This description comes directly from the study's public registry record.
Nyssa Schwager, MSN, RN · 708-217-1146 · nyssa.schwager@duke.edu
Michael J. Satlin, MD, MS · 434-531-6218 · mjs9012@med.cornell.edu
Always discuss trial participation with your own doctor first.
| San Francisco Public Health Laboratory | San Francisco, California, United States | Recruiting |
| Indiana University School of Medicine | Indianapolis, Indiana, United States | Recruiting |
| Mississippi State Department of Public Health | Jackson, Mississippi, United States | Recruiting |
| Corewell Health | Royal Oak, Missouri, United States | Recruiting |
| LabCorp | Durham, North Carolina, United States | Recruiting |
| ARUP Laboratories | Salt Lake City, Utah, United States | Recruiting |
| University of Virginia School of Medicine | Charlottesville, Virginia, United States | Recruiting |
| Molecular Testing Labs | Vancouver, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06815536